Overview


According to FutureWise analysis the market for Veterinary Biologics in 2023 is US$ 12.16 billion, and is expected to reach US$ 21.09 billion by 2031 at a CAGR of 7.10%.

Biologics drugs are used for boosting the immune system to defend the body against infections. Veterinary biologics products are derived from biological processes and living organisms. They are used for preventing, treating or diagnosing animal function and diseases using an immunological procedure. Rising occurrence of chronic animal diseases, increased emphasis of key players in R D of novel veterinary biological products in combating newly emerged animal diseases are predicted to boost the veterinary biologics market growth. Furthermore, growing investments made by government organizations and increased insistence for meat, milk, fish and eggs are some other factors responsible for the proliferation of the market. Moreover, technological advancement in veterinary biologics like immunomodulators and monoclonal antibodies shall boost the market growth. For instance, Zoetis’s Cytopoint, which is the first of its kind monoclonal antibody for veterinary use by EU.

  • Zoetis Inc.
  • Merck Animal Health
  • Boehringer Ingelheim GmbH
  • Bayer AG
  • Eli Lilly and Company
  • Abaxis
  • OMEGA
  • Hebei Veyong Animal Pharmaceutical Co. Ltd.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Diagnostic Kits
  • Vaccines
    • Inactivated Vaccines
    • Conjugate Vaccines
    • Live Attenuated
    • Toxoid Vaccines 
  • Antiserums and Antibodies
  • Immunomodulators
  • Others     

By Animal Type 

  • Companion Animals
  • Livestock Animals    

By Disease Type

  • Foot & Mouth Disease
  • Tuberculosis and Brucellosis
  • Bluetongue
  • Others

By Distribution Channel

  • Veterinary Clinics
  • Veterinary Hospitals 
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

The market is categorised into product, animal type, disease type, distribution channel and region. The product segment is diversified into diagnostic kits, vaccines, antiserums and antibodies, immunomodulators and others. The vaccines segment is predicted to hold the largest veterinary biologics market share owing to technological advancements in vaccine development along with consistent resistance of drugs by pathogens. Furthermore, the development of veterinary vaccines has preclinical trial requirements and non-stringent regulations. Thus, emerging market players have the opportunity of entering the market with advanced product developments. The animal type segment is classified into companion animals and livestock animals. Veterinary biologics are mainly used on livestock animals which is the reason this segment is predicted to lead the market during the forecast period. The disease type segment is fragmented into foot & mouth disease, tuberculosis and brucellosis, bluetongue and others. The distribution channel segment is diversified into veterinary clinics, veterinary hospitals and others. The veterinary hospitals segment is predicted to lead the market owing to bolstering governmental support along with the provision of all veterinary treatments.

The North America region subjugated the market due to rising issues regarding pet healthcare and high product costs. Favourable support from the government for developing novel biologic drugs is predicted to boost the market in the European region. The Biotechnology and Biological Sciences Research Council, in December 2015, funded over 5 million GBP for developing poultry vaccines to the London School of Tropical Medicine and Hygiene. Mandates in government necessities for animal immunization, increasing demand for zoonotic and rising ownership of companion animals are some of the veterinary biologics market trends in the Asia Pacific region.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key market trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the global veterinary biologics market by product, by animal type, by disease type, by distribution channel and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.  Veterinary Biologics Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework on Country Level
         6.1 . Reimbursement Framework
         6.2 . Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1 . Market Driver Analysis
         1.2 . Market Restraint Analysis
         1.3 . Industry Challenges
  • 6.   Veterinary Biologics Market Analysis Tools

    •   1. Industry Analysis - Porter’s
         1.1 . Supplier Power
         1.2 . Buyer Power
         1.3 . Substitution Threat
         1.4 . Threat from new entrants
         1.5 . Competitive Rivalry
        2. Pestel Analysis
         2.1 . Political Landscape
         2.2 . Environmental Landscape
         2.3 . Social landscape
         2.4 . Technology landscape
         2.5 . Legal Landscape

  • 7.   Veterinary Biologics Market, By Product Historical Analysis 2017-2022 and Forecast 2023-2031 (USD million)

    •   1. Diagnostic Kits
        2. Vaccines
         2.1. Inactivated Vaccines
         2.2. Conjugate Vaccines
         2.3. Live Attenuated
         2.4. Toxoid Vaccines
         2.5. Others
        3. Antiserums and Antibodies
        4. Immunomodulators
        5. Others

  • 8.   Veterinary Biologics Market, By Animal Type Historical Analysis 2017-2022 and Forecast 2023-2031 (USD million)

    •   1. Companion Animals
        2. Livestock Animals

  • 9.   Veterinary Biologics Market, By Disease Type Channel Historical Analysis 2017-2022 and Forecast 2023-2031 (USD million)

    •   1. Foot & Mouth Disease
        2. Tuberculosis and Brucellosis
        3. Bluetongue
        4. Others

  • 10.   Veterinary Biologics Market, By Distribution Channel Historical Analysis 2017-2022 and Forecast 2023-2031 (USD million)

    •   1 . Veterinary Clinics
        2 . Veterinary Hospitals
        3 . Others

  • 11.   North America Veterinary Biologics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.
         2.2. Canada
         2.3. Mexico
         2.4. Rest of North America
        3 . Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Veterinary Biologics Market Analysis 2017-2022 and Forecast 2017-2022 (USD Million)

    •   1. Introduction
        2. Regional Market Trends
        3. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         3.1. Brazil
         3.2. Venezuela
         3.3. Argentina
         3.4. Rest of Latin America
        4 . Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Veterinary Biologics Market Analysis 2017-2022 and Forecast 2017-2022 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Switzerland
         2.6. Spain
         2.7. Russia
         2.8. Poland
         2.9. Rest of Western Europe
        3 . Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Veterinary Biologics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. Singapore
         2.4. Korea
         2.5. India
         2.6. Australia and New Zealand
         2.7. ASEAN
         2.8. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.  Middle East and Africa Veterinary Biologics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. UAE
         2.2. South Africa
         2.3. Egypt
         2.4. Saudi Arabia
         2.5. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.  Market Share Analysis and Competitive Landscape

    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)

    •   1. Zoetis Inc.
         1.1. Company Overview (HQ, Business Segments, Employee Strength)
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Merck Animal Health
         2.1. Company Overview (HQ, Business Segments, Employee Strength)
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Boehringer Ingelheim GmbH
         3.1. Company Overview (HQ, Business Segments, Employee Strength)
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Bayer AG
         4.1. Company Overview (HQ, Business Segments, Employee Strength)
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Eli Lilly and Company
         5.1. Company Overview (HQ, Business Segments, Employee Strength)
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Abaxis
         6.1. Company Overview (HQ, Business Segments, Employee Strength)
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. OMEGA
         7.1. Company Overview (HQ, Business Segments, Employee Strength)
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Hebei Veyong Animal Pharmaceutical Co. Ltd.
         8.1. Company Overview (HQ, Business Segments, Employee Strength)
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview

  • 18.  Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.   Competitive Intelligence and Competitive Matrix

    •   1. Competitive Intelligence
        2. Competitive Matrix

  • 20.   Major Deals and Strategic Alliances Analysis

    •   1. Joint ventures
        2. Mergers and acquisitions
        3. Licensing and partnerships
        4. Technology Collaborations
        5. Strategic Divestments
        6. Market Entry Strategies

  • 21.   Relevant Case Studies and Latest News Updates
  • 22.  FutureWise SME Key Takeaway Points for Client

    •   


Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11